India · Delayed Price · Currency is INR DCM Shriram Earnings Call Transcripts
Fiscal Year 2026
-
Q3 FY26 saw 13% revenue growth and 4% PBDIT rise, led by chemicals, sugar, ethanol, and agri inputs. Major chemical investments are nearing completion, with steady growth and margin improvement expected from FY27. Fenesta margins should stabilize as new capacities ramp up.
-
Q2 FY26 saw 11% revenue and 74% EBITDA growth, led by Chemicals and Shriram Farm Solutions. Strategic integration, new projects, and acquisitions are driving expansion, while the company manages risks from oversupplied markets and volatile prices.
-
Q1FY26 saw 13% revenue and 19% PBDIT growth, led by chemicals and agri inputs, despite headwinds in sugar/ethanol and PVC. Strategic CapEx, new product launches, and acquisitions support future growth, while regulatory and global risks persist.
Fiscal Year 2025
-
Q4 and FY25 saw double-digit revenue and profit growth, led by chemicals, agri-inputs, and sugar, with strong cash flows and a healthy balance sheet. Major CapEx projects are nearing completion, and the company is advancing in renewables, digitalization, and business reorganization.
-
Q3 FY25 saw 11% revenue and 12% PBDIT growth, led by chemicals and agri-inputs, with strong capacity expansion and cost optimization initiatives underway. Margins in sugar remain pressured, while new projects in advanced materials and renewables are progressing.
-
Q2 FY25 saw 9% YoY revenue growth and 73% YoY PBDIT increase, led by chemicals and SFS. Strategic capex in chemicals and Fenesta, improved margins, and strong segmental growth were offset by global volatility and pricing pressures. ROCE declined to 15% due to recent investments.
-
Q1 FY25 saw strong growth in chemicals and vinyl, offset by margin pressure in sugar due to higher costs and no exports. New capacities in caustic and power were commissioned, with further ramp-up and downstream expansions planned. Net revenues rose 3% year-over-year to INR 2,876 crore.